Fresenius Medical Care Deutschland GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public, Subsidiary
- Established
- 1912-01-01
- Employees
- 10K
- Market Cap
- -
Clinical Trials
51
Active:9
Completed:28
Trial Phases
5 Phases
Phase 1:4
Phase 2:1
Phase 3:2
+2 more phases
Drug Approvals
30
CIMA_AEMPS:26
PHILIPPINES:3
NPRA:1
Drug Approvals
BICAVERA GLUCOSA 1,5%, CALCIO 1,25 MMOL/L SOLUCION PARA DIALISIS PERITONEAL
- Approval Date
- Jul 14, 2025
CIMA_AEMPS
BALANCE 4,25 % GLUCOSA, 1,25 mmol/L DE CALCIO, SOLUCION PARA DIALISIS PERITONEAL
- Approval Date
- Jul 14, 2025
CIMA_AEMPS
BICAVERA GLUCOSA 2,3%, Calcio 1,75 mmol/l SOLUCION PARA DIALISIS PERITONEAL
- Approval Date
- Jul 14, 2025
CIMA_AEMPS
BALANCE 2,3 % GLUCOSA, 1,75 mmol/L DE CALCIO, SOLUCION PARA DIALISIS PERITONEAL
- Approval Date
- Jul 14, 2025
CIMA_AEMPS
MULTIBIC 2 MMOL/L DE POTASIO SOLUCIÓN PARA HEMODIÁLISIS Y HEMOFILTRACIÓN
- Approval Date
- Jul 14, 2025
CIMA_AEMPS
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials
Not Applicable
23 (74.2%)Phase 1
4 (12.9%)Phase 3
2 (6.5%)Phase 2
1 (3.2%)Phase 4
1 (3.2%)Efficacy and Tolerability of the APD Treatment in PAED Patients
Not Applicable
Not yet recruiting
- Conditions
- Renal Failure Acute Chronic
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 13
- Registration Number
- NCT07004907
Analysis of Paediatric Treatments with MultiFiltratePRO
Not Applicable
Not yet recruiting
- Conditions
- Renal FailureCVVHD
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 43
- Registration Number
- NCT06603324
Influence of Variable Inflow Volume, Dwell Duration and Glucose Concentration on Ultrafiltration Volume in APD Patients
Not Applicable
Not yet recruiting
- Conditions
- Renal FailureChronic Kidney Diseases
- First Posted Date
- 2024-06-05
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 10
- Registration Number
- NCT06443021
Clinical Performance of the Therapy Option FlexPoint of the PD Cycler Sleep•Safe Harmony
Not Applicable
Not yet recruiting
- Conditions
- Renal FailureChronic Kidney Disease
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 24
- Registration Number
- NCT06390592
Clinical Performance of the New Plasma Filter PX2 in TPE Treatments
Not Applicable
Recruiting
- Conditions
- Autoimmune Diseases
- First Posted Date
- 2024-04-24
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 46
- Registration Number
- NCT06382675
- Locations
- 🇩🇪
St. Vincenz Kliniken, Paderborn, Nordrhein-Westfalen, Germany
🇩🇪Charité-Universitätsmedizin Berlin, Berlin, Germany
🇩🇪Klinikum Aschaffenburg-Alzenau, Aschaffenburg, Bavaria, Germany
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
No news found